Does furosemide plus hypertonic saline lower biomarker levels in acute decompensated heart failure?
In acute decompensated heart failure (ADHF), doctors often use intravenous furosemide to remove excess fluid. Adding a small volume of hypertonic saline solution (HSS) is a strategy some clinicians use to potentially improve decongestion. The question is whether this combination also lowers levels of key biomarkers—such as NT-proBNP, a marker of heart strain—more than furosemide alone. Evidence from randomized trials suggests that furosemide plus HSS may blunt the rise in certain biomarkers after a saline challenge, though the effect on initial biomarker reduction is less clear.
What the research says
A 2021 randomized trial of 141 ADHF patients with reduced ejection fraction found that those treated with high-dose furosemide plus HSS had significantly higher absolute decreases in IL-6, sST2, NT-proBNP, and hsTnT compared to furosemide alone 10. However, the between-group analysis showed a comparable degree of reduction in these biomarkers, meaning the overall change from admission to after treatment was similar in both groups 10. A larger 2026 trial of 200 patients confirmed that furosemide plus HSS led to significantly lower increases in IL-6, hsTnT, sST2, galectin-3, and NT-proBNP after a saline load (a test of how the heart handles extra fluid) 89. This suggests the combination may protect against biomarker spikes during fluid challenges, which could reflect better hemodynamic stability. The same study also observed changes in epigenetic markers, including a decrease in miR181b expression, indicating potential effects on gene regulation 89. It is important to note that these findings come from specific patient populations (those with heart failure with reduced ejection fraction) and may not apply to all ADHF patients. Additionally, other sources in the provided set do not directly address the furosemide-plus-HSS combination; they focus on different diuretic strategies or unrelated topics 1234567.
What to ask your doctor
- Could adding hypertonic saline to my furosemide treatment help control my heart failure biomarkers?
- What are the potential risks or side effects of receiving hypertonic saline with diuretics?
- Is this combination appropriate for my specific type of heart failure (e.g., reduced vs. preserved ejection fraction)?
- How would we monitor the effectiveness of this treatment, such as through blood tests for NT-proBNP or other markers?
- Are there any alternative strategies to improve diuretic response if furosemide alone is not enough?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.